Tatva Chintan Pharma Chem Limited

NSEI:TATVA Stock Report

Market Cap: ₹24.0b

Tatva Chintan Pharma Chem Valuation

Is TATVA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of TATVA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: TATVA (₹1027.6) is trading above our estimate of fair value (₹334.96)

Significantly Below Fair Value: TATVA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for TATVA?

Other financial metrics that can be useful for relative valuation.

TATVA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue6.2x
Enterprise Value/EBITDA37.7x
PEG Ratio2x

Price to Earnings Ratio vs Peers

How does TATVA's PE Ratio compare to its peers?

The above table shows the PE ratio for TATVA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average53.4x
590013 Xpro India
52.7xn/a₹24.5b
PLATIND Platinum Industries
41.7xn/a₹20.8b
541167 Yasho Industries
55xn/a₹22.4b
500078 Oriental Aromatics
64.3xn/a₹16.8b
TATVA Tatva Chintan Pharma Chem
92.2x45.5%₹24.0b

Price-To-Earnings vs Peers: TATVA is expensive based on its Price-To-Earnings Ratio (92.2x) compared to the peer average (53.4x).


Price to Earnings Ratio vs Industry

How does TATVA's PE Ratio compare vs other companies in the IN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a20.8%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a20.8%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: TATVA is expensive based on its Price-To-Earnings Ratio (92.2x) compared to the Indian Chemicals industry average (36.2x).


Price to Earnings Ratio vs Fair Ratio

What is TATVA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

TATVA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio92.2x
Fair PE Ratio44.5x

Price-To-Earnings vs Fair Ratio: TATVA is expensive based on its Price-To-Earnings Ratio (92.2x) compared to the estimated Fair Price-To-Earnings Ratio (44.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst TATVA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,027.60
₹1,366.50
+33.0%
27.6%₹1,925.00₹1,020.00n/a4
Sep ’25₹959.85
₹1,366.50
+42.4%
27.6%₹1,925.00₹1,020.00n/a4
Aug ’25₹992.55
₹1,366.50
+37.7%
27.6%₹1,925.00₹1,020.00n/a4
Jul ’25₹1,135.25
₹1,608.25
+41.7%
21.4%₹1,975.00₹1,223.00n/a4
Jun ’25₹1,033.75
₹1,674.25
+62.0%
16.9%₹1,975.00₹1,310.00n/a4
May ’25₹1,228.10
₹1,674.25
+36.3%
16.9%₹1,975.00₹1,310.00n/a4
Apr ’25₹1,119.50
₹1,674.25
+49.6%
16.9%₹1,975.00₹1,310.00n/a4
Mar ’25₹1,221.75
₹1,674.25
+37.0%
16.9%₹1,975.00₹1,310.00n/a4
Feb ’25₹1,330.90
₹1,674.25
+25.8%
16.9%₹1,975.00₹1,310.00n/a4
Jan ’25₹1,598.40
₹1,847.25
+15.6%
10.0%₹2,000.00₹1,530.00n/a4
Dec ’24₹1,564.95
₹1,847.25
+18.0%
10.0%₹2,000.00₹1,530.00n/a4
Nov ’24₹1,449.75
₹1,847.25
+27.4%
10.0%₹2,000.00₹1,530.00n/a4
Oct ’24₹1,582.90
₹1,874.75
+18.4%
11.3%₹2,110.00₹1,530.00₹1,033.254
Sep ’24₹1,722.15
₹1,874.75
+8.9%
11.3%₹2,110.00₹1,530.00₹959.854
Aug ’24₹1,656.75
₹1,901.00
+14.7%
9.0%₹2,110.00₹1,635.00₹992.554
Jul ’24₹1,843.25
₹1,901.00
+3.1%
9.0%₹2,110.00₹1,635.00₹1,135.254
Jun ’24₹1,654.35
₹1,901.00
+14.9%
9.0%₹2,110.00₹1,635.00₹1,033.754
May ’24₹1,734.60
₹2,492.00
+43.7%
5.8%₹2,650.00₹2,300.00₹1,228.103
Apr ’24₹1,669.05
₹2,492.00
+49.3%
5.8%₹2,650.00₹2,300.00₹1,119.503
Mar ’24₹1,909.70
₹2,492.00
+30.5%
5.8%₹2,650.00₹2,300.00₹1,221.753
Feb ’24₹2,071.80
₹2,551.00
+23.1%
6.3%₹2,728.00₹2,300.00₹1,330.904
Jan ’24₹2,150.65
₹2,609.00
+21.3%
8.0%₹2,860.00₹2,300.00₹1,598.404
Dec ’23₹2,237.90
₹2,609.00
+16.6%
8.0%₹2,860.00₹2,300.00₹1,564.954
Nov ’23₹2,415.95
₹2,601.50
+7.7%
5.3%₹2,730.00₹2,400.00₹1,449.754
Oct ’23₹2,517.15
₹2,601.50
+3.4%
5.3%₹2,730.00₹2,400.00₹1,582.904

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies